Dose-aware Diffusion Model for 3D Low-dose PET: Multi-institutional Validation with Reader Study and Real Low-dose Data
Reducing scan times, radiation dose, and enhancing image quality, especially for lower-performance scanners, are critical in low-count/low-dose PET imaging. Deep learning (DL) techniques have been investigated for PET image denoising. However, existing models have often resulted in compromised image...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Reducing scan times, radiation dose, and enhancing image quality, especially
for lower-performance scanners, are critical in low-count/low-dose PET imaging.
Deep learning (DL) techniques have been investigated for PET image denoising.
However, existing models have often resulted in compromised image quality when
achieving low-dose PET and have limited generalizability to different image
noise-levels, acquisition protocols, and patient populations. Recently,
diffusion models have emerged as the new state-of-the-art generative model to
generate high-quality samples and have demonstrated strong potential for
medical imaging tasks. However, for low-dose PET imaging, existing diffusion
models failed to generate consistent 3D reconstructions, unable to generalize
across varying noise-levels, often produced visually-appealing but distorted
image details, and produced images with biased tracer uptake. Here, we develop
DDPET-3D, a dose-aware diffusion model for 3D low-dose PET imaging to address
these challenges. Collected from 4 medical centers globally with different
scanners and clinical protocols, we extensively evaluated the proposed model
using a total of 9,783 18F-FDG studies (1,596 patients) with low-dose/low-count
levels ranging from 1% to 50%. With a cross-center, cross-scanner validation,
the proposed DDPET-3D demonstrated its potential to generalize to different
low-dose levels, different scanners, and different clinical protocols. As
confirmed with reader studies performed by nuclear medicine physicians,
experienced readers judged the images to be similar to or superior to the
full-dose images and previous DL baselines based on qualitative visual
impression. The presented results show the potential of achieving low-dose PET
while maintaining image quality. Lastly, a group of real low-dose scans was
also included for evaluation to demonstrate the clinical potential of DDPET-3D. |
---|---|
DOI: | 10.48550/arxiv.2405.12996 |